Bitot spots are small, foamy or cheese-like patches that form on the white of the eye and serve as one of the earliest visible signs that the body is running dangerously low on vitamin A. They consist of a buildup of the protein keratin on the conjunctiva, the clear membrane covering the eye’s surface, and they signal a condition called xerophthalmia, the spectrum of eye disease caused by vitamin A deficiency.1PubMed Central. Immunohistochemistry in an Adult Case of Bitot’s Spots Caused by Vitamin A Deficiency While the name sounds exotic, the spots themselves are surprisingly common in parts of the world where childhood malnutrition persists, and they carry real consequences if ignored.
What Bitot Spots Actually Look Like
If you were to look at someone’s eye with Bitot spots, you’d see a slightly raised, whitish or silvery patch on the exposed part of the conjunctiva, usually on the side of the eye closest to the ear (the temporal side). They have a distinctive foamy or bubbly texture that some clinicians describe as resembling dried soap suds or cottage cheese. Classically, the spots appear at the 3 o’clock and 9 o’clock positions on the eye, corresponding to the areas of the conjunctiva most exposed to air and sunlight when the eyelids are open.2PubMed Central. Keratomalacia and corneal perforation in vitamin A deficiency – Section: Introduction They can appear in one eye or both, and in young children they sometimes go unnoticed by parents because the child doesn’t complain of pain. The spots themselves are typically painless, though the eye may feel dry or gritty because the surface is no longer producing the protective mucus layer it normally does.
How They Form
Vitamin A is essential for maintaining the health of the conjunctiva. Without enough of it, the specialized cells on the eye’s surface start to undergo a transformation called keratinization, essentially hardening into something closer to skin than the soft, moist tissue they’re supposed to be. The cells that normally produce mucus, known as goblet cells, disappear from the affected area. Research on tissue samples from Bitot spots has confirmed this: studies show a clear expression of keratinization-related proteins alongside a complete absence of mucin-producing goblet cells, pointing directly to impaired cell development caused by the vitamin deficiency.3PubMed Central. Immunohistochemistry in an Adult Case of Bitot’s Spots Caused by Vitamin A Deficiency
This matters because the eye depends on its tear film and goblet cell secretions to stay clear and healthy. When those cells disappear and the surface dries out and hardens, the waxy keratin debris accumulates, and bacteria (especially Corynebacterium xerosis) colonize the rough, abnormal surface. The foamy appearance of the spots is partly produced by gas released by these bacteria thriving in the keratinized tissue. So the spot you see is essentially a combination of a structural change in the tissue itself and a bacterial colony taking advantage of the altered terrain.
Who Is at Risk
Bitot spots are overwhelmingly a disease of poverty and malnutrition. They are most common in children between the ages of one and five in low- and middle-income countries, particularly in South Asia and sub-Saharan Africa. Vitamin A deficiency remains a leading cause of preventable childhood blindness in these regions, with Bitot spots and night blindness as the earliest clinical manifestations.4PubMed Central. Prevalence of vitamin A deficiency in South Asia: causes, outcomes, and possible remedies The dietary patterns that drive deficiency tend to follow a recognizable pattern: early cessation of breastfeeding, poor quality of weaning foods, and infrequent consumption of foods rich in vitamin A, such as liver, eggs, dark leafy greens, and orange-fleshed vegetables.5Food and Nutrition Bulletin. Dietary Vitamin-a Deficiency: Effects on Growth, Infection, and Mortality
Adults can develop Bitot spots too, though it’s far less common in high-income countries. When it does occur in adults in wealthier nations, the cause is rarely simple dietary insufficiency. Instead, it tends to stem from conditions that interfere with how the body absorbs fat-soluble vitamins: chronic liver disease, celiac disease, inflammatory bowel disease, chronic alcoholism, or the aftermath of bariatric surgery. Any condition that disrupts fat absorption can starve the body of vitamin A even when the diet seems adequate.
Treatment and What to Expect
The standard treatment is high-dose vitamin A supplementation, sometimes called mega-dose vitamin A supplementation (MVAS). For children, the World Health Organization protocol involves administering large oral doses of vitamin A at the time of diagnosis, with a repeat dose shortly after. The expectation is that the spots will resolve as the body’s vitamin A stores are replenished and the conjunctival surface begins to heal.
In practice, the response is slower and less predictable than many clinicians and parents expect. A study following 262 children aged one to five with confirmed Bitot spots found that about half were cured at six months after receiving two high-dose treatments a month apart. By one year, with an additional dose at the six-month mark, roughly 60% had fully resolved.6PubMed Central. Resolution of Bitot’s spots following mega-dose vitamin A supplementation in children between 1 and 5 years of age Among those who did clear by six months, the timeline was encouraging: about half resolved within two months, and three-quarters were gone by three months. But the flip side is that around 40% of children still had visible Bitot spots a full year after treatment began, suggesting that a sizable proportion of cases are either not purely caused by vitamin A deficiency or involve structural changes in the conjunctiva that take much longer to reverse.
Dose size also matters for staying better. Research comparing single oral doses found that both lower and higher doses were similarly effective at initially healing the spots. However, children who received the higher dose were substantially less likely to relapse: by six months after treatment, those given the larger dose had an 82% lower chance of the spots returning compared to those given the smaller dose.7PubMed. Response of Bitot’s spots to a single oral 100,000- or 200,000-IU dose of vitamin A The strongest predictor of whether treatment would work was how low the child’s vitamin A levels were to begin with. Counterintuitively, children with the most severe deficiency were the most likely to respond, because their spots were more clearly caused by the deficiency itself rather than some other factor.
What Happens to the Eye Surface During Recovery
When vitamin A supplementation works, the healing process on the eye’s surface follows a specific sequence. The cornea, the clear dome at the front of the eye, tends to heal first. In patients with more advanced disease involving corneal damage, the cornea can begin to recover within days of starting treatment. The goblet cells, the mucus-producing cells that had disappeared from the conjunctiva, take longer to come back. Studies of conjunctival biopsies in patients recovering from corneal xerophthalmia showed that goblet cells began to repopulate the tissue about two weeks after high-dose vitamin A therapy and reached normal concentrations after about a month.8ScienceDirect (American Journal of Ophthalmology). Goblet Cell Response to Vitamin a Treatment for Corneal Xerophthalmia
An interesting finding from this work is that the cornea healed well before the goblet cells had fully recovered. This suggests that a complete population of mucus-secreting cells isn’t actually required for the cornea to look and function normally, at least in the short term. For Bitot spots specifically, the foamy keratinized patch may persist for weeks or months after the underlying tissue has begun to normalize, partly because clearing away accumulated keratin debris is a slower process than restoring the cellular machinery beneath it.
When the Spots Have Nothing to Do with Vitamin A
One of the more surprising findings in ophthalmology is that patches visually and even microscopically identical to Bitot spots can appear in people whose vitamin A levels are perfectly normal. Researchers identified a group of children with these “Bitot-like spots” whose blood tests showed no deficiency at all. The lesions were indistinguishable from classic Bitot spots both clinically and under the microscope. These children turned out to have a range of other anterior segment eye conditions, including aniridia (absence of the iris), WAGR syndrome, Axenfeld-Rieger syndrome, and blepharokeratoconjunctivitis (chronic inflammation of the eyelids and conjunctiva).9Eye. Bitot-like spots in children with normal vitamin A levels
This matters for two reasons. First, it means that seeing a Bitot spot does not automatically confirm vitamin A deficiency. In a clinical setting, especially in countries where deficiency is less common, these lookalikes can send a doctor down the wrong diagnostic path. Second, it helps explain why a substantial chunk of Bitot spots don’t respond to vitamin A supplementation. If the underlying problem is chronic ocular surface inflammation or a genetic eye condition rather than a nutritional deficiency, no amount of vitamin A is going to make the spots disappear.
The study’s authors suggested that Bitot-like spots in children with normal vitamin A levels represent a shared endpoint of conjunctival surface damage from different causes. The keratinization process isn’t unique to vitamin A deficiency; it’s the conjunctiva’s general response to chronic insult. Vitamin A deficiency just happens to be the most common trigger worldwide.
What Happens if Bitot Spots Go Untreated
Bitot spots sit relatively early on the spectrum of xerophthalmia, which is the collective term for all the eye damage caused by vitamin A deficiency. The progression, when deficiency persists, follows a grim sequence. Night blindness usually comes first or appears alongside the spots. After Bitot spots, the next stage is corneal xerosis, where the cornea itself dries out and loses its normal luster. Beyond that lies corneal ulceration and, in the worst cases, keratomalacia: the cornea softens, melts, and can perforate entirely, leading to permanent blindness.10PubMed Central. Keratomalacia and corneal perforation in vitamin A deficiency – Section: Introduction
This progression is why Bitot spots are considered medically important out of proportion to their appearance. On their own, they cause some discomfort but don’t threaten vision. Their significance is as a warning sign. A child with Bitot spots is telling you their body’s vitamin A reserves are depleted, and without intervention, the next stages of eye disease, and potentially systemic problems including increased susceptibility to infection and higher mortality, are approaching. In public health terms, the presence of Bitot spots in a community signals that subclinical vitamin A deficiency is likely widespread and that other children who haven’t yet developed visible signs may also be at risk.
Bitot Spots as a Public Health Indicator
Because Bitot spots are visible without any special equipment, they have long served as a field-level screening tool for vitamin A deficiency in population surveys. A trained examiner can spot them during a brief eye check at a school or community clinic. The World Health Organization uses the prevalence of Bitot spots in children as one of its indicators for assessing the severity of vitamin A deficiency in a population. When more than about half a percent of children in a community show Bitot spots, the WHO considers vitamin A deficiency a significant public health problem in that area.
That said, the evidence suggests Bitot spots are a “relatively crude indicator” of severe current deficiency.11PubMed Central. Resolution of Bitot’s spots following mega-dose vitamin A supplementation in children between 1 and 5 years of age The roughly 40% non-response rate to supplementation at one year means that a substantial number of children counted as vitamin A deficient based on their Bitot spots may actually have spots caused by something else entirely, or may have had deficiency in the past that left behind structural changes even after their vitamin A levels normalized. For individual diagnosis, the spots are a useful initial clue but not a definitive test. Blood levels of retinol provide the actual confirmation.
Conditions Mistaken for Bitot Spots
The foamy or slightly raised conjunctival patches of Bitot spots can look similar to several other eye conditions, which means misidentification runs in both directions: other conditions can be mistaken for Bitot spots, and Bitot spots can occasionally be dismissed as something more benign.
The most clinically consequential lookalike is ocular surface squamous neoplasia (OSSN), a spectrum of abnormal cell growth on the eye’s surface that ranges from precancerous changes to invasive cancer. Bitot spots appear on lists of conditions that should be considered in the differential diagnosis of OSSN, alongside more common findings like pterygium (a wing-shaped growth of tissue on the conjunctiva) and pinguecula (a yellowish, slightly raised bump on the white of the eye).12PubMed Central. Update in ocular surface squamous neoplasia – Section: DIFFERENTIAL DIAGNOSIS In practice, the distinction usually isn’t difficult for an experienced eye doctor. Bitot spots have a characteristic location, bilateral presentation, and foamy texture that set them apart. But in an adult patient with a unilateral conjunctival lesion, especially in a setting where vitamin A deficiency is unlikely, a wider differential is warranted.
Pterygium is probably the most common source of confusion for non-specialists. Both conditions involve abnormal tissue on the conjunctiva, and both favor the sun-exposed areas of the eye. The key difference is that pterygium is a fibrovascular growth that typically extends onto the cornea, while Bitot spots sit flat on the conjunctiva and don’t invade the cornea. Pingueculae, the small yellowish bumps that develop from UV exposure and aging, can also be mistaken for early Bitot spots, though their texture and color are usually different on close inspection.
Why Bitot Spots Persist in Some Patients
One of the more frustrating aspects of managing Bitot spots is that they don’t always go away, even with appropriate vitamin A treatment and confirmed correction of the deficiency. Several factors contribute to this persistence.
The most important, as covered earlier, is that some spots were never caused by vitamin A deficiency in the first place. When keratinization results from chronic surface inflammation, a genetic eye condition, or UV exposure, supplementation addresses the wrong problem.13Eye. Bitot-like spots in children with normal vitamin A levels But even among spots that are genuinely caused by deficiency, long-standing cases can leave behind scarring and structural changes in the conjunctival tissue that don’t fully reverse once vitamin A stores are restored. The longer the deficiency has been present, the more entrenched the keratinized tissue becomes.
There’s also the issue of reinfection and ongoing nutritional deprivation. In communities where vitamin A deficiency is endemic, a child treated with a high dose may return to the same diet that caused the deficiency. Without sustained dietary improvement or regular supplementation programs, relapse is common. The finding that higher-dose treatment reduced relapse risk by 82% over six months makes sense in this context: a larger initial dose buys the child more time with adequate stores, even if the diet remains poor.14PubMed. Response of Bitot’s spots to a single oral 100,000- or 200,000-IU dose of vitamin A But no single dose lasts forever. Sustained prevention ultimately depends on improving diets, fortifying staple foods, or maintaining periodic supplementation programs.
Bitot Spots in Adults in High-Income Countries
Although rare, Bitot spots do occasionally turn up in adults in wealthy nations, and these cases tend to puzzle the clinicians who encounter them. The most common scenario involves a patient with a chronic condition affecting nutrient absorption. Alcoholism with liver damage is a classic setting, since the liver is the body’s primary vitamin A storage depot. Patients who have undergone bariatric surgery, particularly procedures that bypass portions of the small intestine, can develop vitamin A deficiency years after the operation if they don’t maintain strict supplementation regimens. Crohn’s disease and celiac disease, when poorly controlled, can also deplete vitamin A levels enough to produce ocular signs.
What makes these cases tricky is that the doctor may not think of vitamin A deficiency at all. In a country where the condition is virtually unheard-of in the general population, a white patch on the conjunctiva is more likely to prompt concerns about a growth or an allergic reaction than about a nutritional deficiency. Case reports from Europe and North America describe patients who went through multiple specialist consultations before someone thought to check their vitamin A level. For patients with known malabsorption conditions, being aware that the eyes can signal vitamin A depletion before any other obvious symptom appears is genuinely useful information. Night blindness may precede or accompany the spots, but patients often attribute worsening night vision to aging or general eye changes rather than connecting it to their underlying condition.
When correctly diagnosed, adult Bitot spots caused by true deficiency tend to respond well to supplementation, often faster than in children in endemic areas. This may reflect the fact that adults in these situations usually have access to high-quality medical care, dietary counseling, and reliable supplement supply, so the underlying deficiency can be corrected thoroughly and monitored over time.